Home Clinical Topics FDA approves Tivicay for HIV infection

FDA approves Tivicay for HIV infection

On August 12, the U.S. Food and Drug Administration (FDA) approved Tivicay (dolutegravir), a new drug to treat HIV-1 infection. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here